These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 914689)

  • 21. Vaccination against measles: a clinical trial of live measles vaccine given alone and live vaccine preceded by killed vaccine. A report to the Medical Research Council by the Measles Vaccines Committee.
    Br Med J; 1966 Feb; 1(5485):441-6. PubMed ID: 5902680
    [No Abstract]   [Full Text] [Related]  

  • 22. Studies on the modification of the live AIK measles vaccine. II. Development and evaluation of the live AIK-C measles vaccine.
    Makino S; Sasaki K; Nakamura N; Nakagawa M; Nakajima S
    Kitasato Arch Exp Med; 1974 Jun; 47(1-2):13-21. PubMed ID: 4476032
    [No Abstract]   [Full Text] [Related]  

  • 23. Measles and the central nervous system. A review.
    Rabin ER
    Mo Med; 1974 May; 71(5):225-7. PubMed ID: 4826357
    [No Abstract]   [Full Text] [Related]  

  • 24. Safety and efficacy of transcutaneous vaccination using a patch with the live-attenuated measles vaccine in humans.
    Etchart N; Hennino A; Friede M; Dahel K; Dupouy M; Goujon-Henry C; Nicolas JF; Kaiserlian D
    Vaccine; 2007 Sep; 25(39-40):6891-9. PubMed ID: 17764789
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical and serological studies with a live further attenuated measles vaccine (Moraten) in Chile].
    Ristori C; Boccardo H; Borgoño JM; Greiber R; Heras E; Carrillo B; Solari G; Concha F
    Rev Med Chil; 1970 Jan; 98(1):42-5. PubMed ID: 4157374
    [No Abstract]   [Full Text] [Related]  

  • 26. Combined viral and bacterial antigens for canine vaccines.
    York CJ
    J Am Vet Med Assoc; 1966 Sep; 149(5):681-5. PubMed ID: 4291220
    [No Abstract]   [Full Text] [Related]  

  • 27. Measles vaccine in dogs: efficacy against aerosol challenge with virulent canine distemper virus.
    Strating A
    J Am Vet Med Assoc; 1975 Jul; 167(1):59-62. PubMed ID: 1150494
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Response to measles virus by puppies with maternally transferred distemper antibodies.
    Baker JA; Sheffy BE; Robson DS; Gilmartin J
    Cornell Vet; 1966 Oct; 56(4):588-94. PubMed ID: 6008347
    [No Abstract]   [Full Text] [Related]  

  • 29. Will the current measles vaccines ever eradicate measles?
    Stephenson J
    Expert Rev Vaccines; 2002 Oct; 1(3):355-62. PubMed ID: 12901574
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vaccinations and risk of central nervous system demyelinating diseases in adults.
    DeStefano F; Verstraeten T; Jackson LA; Okoro CA; Benson P; Black SB; Shinefield HR; Mullooly JP; Likosky W; Chen RT;
    Arch Neurol; 2003 Apr; 60(4):504-9. PubMed ID: 12707063
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of extremely attenuated live measles virus vaccine (CAM-EX).
    Ueda S; Takahashi M; Kurimura T; Minekawa Y; Suzuki N
    Biken J; 1972 Sep; 15(3):173-7. PubMed ID: 4643692
    [No Abstract]   [Full Text] [Related]  

  • 32. [Effect of live mumps vaccine alone and in combination with measles vaccine in infants].
    Vesikari T; Ala-Laurila EL; Heikkinen A; Kuusinen H; Terho A
    Duodecim; 1982; 98(11):839-47. PubMed ID: 7106018
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical safety issues of measles, mumps and rubella vaccines.
    Afzal MA; Minor PD; Schild GC
    Bull World Health Organ; 2000; 78(2):199-204. PubMed ID: 10743285
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Summary of the Symposium on Immunity to Selected Canine Infectious Diseases.
    Zeissig A
    J Am Vet Med Assoc; 1970 Jun; 156(12):1807-17. PubMed ID: 4316295
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of simultaneous administration of live measles vaccine on the "take rate" of live mumps vaccine.
    André FE; Peetermans J
    Dev Biol Stand; 1986; 65():101-7. PubMed ID: 3556770
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protection of mumps in children with various underlying diseases: application of a live attenuated mumps and trivalent measles-rubella-mumps (MRM) vaccines in these children.
    Kanesaki T; Baba K; Tsuda N; Yabuuchi H; Yamanishi K; Takahashi M
    Biken J; 1986 Dec; 29(3-4):63-71. PubMed ID: 3304276
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathogenesis of vaccine strains of measles virus in suckling hamsters.
    Mirchamsy H; Razavi J; Ahurai P
    Acta Virol; 1972 Jun; 16(1):77-9. PubMed ID: 4400679
    [No Abstract]   [Full Text] [Related]  

  • 38. [Thrombocytopenic purpura following immunization with a live vaccine (mumps-measles-rubella vaccination)?].
    Wiersbitzky S; Bruns R; Schröder C; Warmuth M
    Kinderarztl Prax; 1992 Feb; 60(1):28-9. PubMed ID: 1556850
    [No Abstract]   [Full Text] [Related]  

  • 39. Live attenuated measles and mumps viral strain-containing vaccines and hearing loss: Vaccine Adverse Event Reporting System (VAERS), United States, 1990--2003.
    Asatryan A; Pool V; Chen RT; Kohl KS; Davis RL; Iskander JK;
    Vaccine; 2008 Feb; 26(9):1166-72. PubMed ID: 18255204
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Canine measles virus infection as a risk factor in multiple sclerosis. Retrospective epidemiologic study].
    Mititelu G; Bourceanu I; Mititelu T
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1986; 31(2):139-44. PubMed ID: 3749724
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.